Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
Russian Journal of Gastroenterology Hepatology Coloproctology
2023
Ivashkin V.T.
Open Access
Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma
Journal of Neurosurgery Pediatrics
April 2021
Huq S.
Open Access
Repurposing the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
Molecular Cancer Therapeutics
1 September 2020
Huq S.
Critical view on the usage of ribavirin in already existing psychostimulant-use disorder
Current Pharmaceutical Design
2020
Petković B.
All Open Access, Green
Psychomotor activity and body weight gain after exposure to low ribavirin doses in rats: Role of treatment duration
Archives of Biological Sciences
2019
Petković B.
Open Access
Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferonalpha and ribavirin - A prospective study
Srpski Arhiv Za Celokupno Lekarstvo
2017
Ružić M.
Open Access
Changes in hematological parameters with pegylated interferon in chronic hepatitis C virus infected patients
Asian Pacific Journal of Cancer Prevention
1 June 2016
Rehman A.U.
Vitamin D and chronic hepatitis C: Effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin
International Journal of Clinical and Experimental Medicine
30 July 2015
Refaat B.
Activins and follistatin in chronic hepatitis c and its treatment with pegylated-interferon-α based therapy
Mediators of Inflammation
2015
Refaat B.
Open Access
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
World Journal of Gastroenterology
7 November 2014
Abenavoli L.
Open Access
Mysterious linkages between hepatitis C virus genotypes, interleukin-28B genotypes and viral clearance- a meta-analysis
Hepatitis Monthly
2014
Aalaei-Andabili S.H.
Open Access
Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C
Journal of Medical Virology
July 2013
Brochot E.
Silymarin flavonolignans: Structure-activity relationship and biosynthesis
Studies in Natural Products Chemistry
2013
Abouzid S.
Commentary on: The Optimal Dose of Ribavirin for Chronic Hepatitis C: From Literature Evidence to Clinical Practice
Hepatitis Monthly
February 2013
El-Shabrawi M.
Open Access
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis
Brazilian Journal of Infectious Diseases
May 2012
Ucciferri C.
Open Access